Form 8-K - Current report:
SEC Accession No. 0001628280-20-017731
Filing Date
2020-12-23
Accepted
2020-12-23 16:12:53
Documents
18
Period of Report
2020-12-23
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20201223.htm   iXBRL 8-K 36817
2 EX-1.1 exhibit11-8xk.htm EX-1.1 312833
3 EX-5.1 exhibit51-8xk.htm EX-5.1 25509
9 footer1b1.jpg GRAPHIC 77047
10 logo1b1.jpg GRAPHIC 67367
  Complete submission text file 0001628280-20-017731.txt   775797

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20201223.xsd EX-101.SCH 2442
5 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20201223_cal.xml EX-101.CAL 726
6 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20201223_def.xml EX-101.DEF 1663
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20201223_lab.xml EX-101.LAB 24243
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20201223_pre.xml EX-101.PRE 12650
11 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20201223_htm.xml XML 10685
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 201412374
SIC: 2834 Pharmaceutical Preparations